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Abstract
Background: Scurvy is one of the oldest diseases known to mankind. Although presently rare in the developed
world, scurvy was a common potentially fatal disease. In recent times, the most common risk factors for scurvy
include alcoholism, low socioeconomic status, and severely poor nutrition or dietary restriction secondary to
psychiatric illness or developmental disorders. Our case demonstrates the importance of having a high index of
clinical suspicion of an uncommon disease in developed countries and emphasizes the necessity of a dietary
screening that could potentially reduce extensive work-up in patients with nonspecific complaints.
Case presentation: We report a case of a 3-year-old previously healthy female originally seen in the rheumatology
clinic for limp. She developed weakness and was admitted to the hospital for further evaluation. She underwent
extensive diagnostic testing including blood work, magnetic resonance imaging, lumbar puncture, electromyogram,
and nerve conduction studies. Ultimately, her vitamin C level returned undetectable. She had immediate and
complete improvement upon starting vitamin C supplementation.
Conclusions: Despite being developmentally appropriate, our patient’s refusal to eat fruits or vegetables had
limited her diet, emphasizing the importance of obtaining a diet history in a child presenting with an unknown
diagnosis. In addition, our patient had no other characteristic features of scurvy, which further supports the need to
consider this diagnosis in a child presenting with lower extremity weakness or abnormal gait.
Keywords: Scurvy, Difficulty walking, Muscle weakness

Background
Scurvy is characterized by a deficiency of vitamin C, also
known as ascorbic acid, a water-soluble micronutrient
responsible for the production of collagen and carnitine,
and the biosynthesis of catecholamines [1]. Humans lack
the gene for L-gulonolactone oxidase, an enzyme that
converts glucose into ascorbic acid. Thus, vitamin C is
an essential exogenous vitamin that when deficient
results in myriad symptoms first described in 1550 BC in
the Papyrus of Ebers [2–4]. From the world’s first
controlled clinical trial in 1753 to determine the role of
citrus in the treatment of scurvy, to the isolation and
identification of ascorbic acid in 1931, vitamin C
deficiency is now easily preventable and treatable [4].
There are many cases of scurvy in the literature primarily involving children with severe dietary restrictions
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secondary to developmental delay or autism spectrum
disorder [2, 5–8]. The clinical manifestations of scurvy
are vast. Scurvy can be diagnosed with laboratory testing
or with empiric ascorbic acid supplementation, which
yields rapid clinical recovery. Despite the ease of treatment, scurvy frequently goes undetected for extended
periods of time and can even be fatal. It requires an
astute physician to recognize the signs and symptoms
and consider the diagnosis of scurvy, especially in
developed countries where many physicians have never
encountered this disease.

Case presentation
A 3-year-old previously healthy girl was seen in the
rheumatology clinic for a persistent limp of 3 weeks’
duration. There was no known history of trauma. She
was able to bear weight but reported right knee pain
exacerbated by walking and climbing stairs. She had no
pain at rest and no nighttime awakenings. She had no
fevers, rashes, rhinorrhea, cough, sore throat, vomiting,
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or diarrhea. The patient was a “picky eater,” but she was
growing appropriately and had met all of her developmental milestones. After the limp had persisted for 2
weeks, she had seen her pediatrician, who performed a
right hip radiograph, complete blood count with differential, comprehensive metabolic panel, and erythrocyte
sedimentation rate. These were unremarkable except for
microcytic anemia with a hemoglobin level of 10.2 g/dL
(mean corpuscular volume [MCV] 73 fL, red cell distribution width [RDW] 16%).
At the rheumatology visit, her weight was at the 46th
percentile, and her height was at the 83rd percentile.
Her vital signs were within normal limits. She had a
normal examination of her eyes, mouth, throat, neck,
lungs, heart, abdomen, and skin. Her musculoskeletal
exam demonstrated normal strength and no tenderness
to palpation of her lower extremities. She had intermittent guarding with movement of her right knee but no
erythema, warmth, tenderness, limited range of motion
or swelling to this joint; the remainder of her joint exam
was normal. She had an antalgic gait with minimal right
knee movement and favored the right side. Neurologic
examination revealed normal mental status, cranial
nerve exam, tone, and patellar deep tendon reflexes.
The differential at that time was broad and included
infectious, mechanical, inflammatory, oncologic, neurologic, and intra-abdominal etiologies. Initial laboratory
work-up included a complete blood count with differential, peripheral smear, and C-reactive protein, which was
remarkable for a hemoglobin level of 10.2 g/dL (MCV
70.2 fL, RDW 14.8%) (Table 1). Peripheral smear showed
mild microcytic hypochromic anemia without blasts or
abnormal cells. A radiograph of her right lower extremity demonstrated mild osteopenia, and a right hip and
knee ultrasound were normal. She was discharged home
on a non-steroidal anti-inflammatory medication with a
plan to obtain additional imaging as an outpatient.
Over the next 7 days, the patient developed progressive weakness. Parental videos showed the patient exhibiting a Gowers’ sign and having difficulty ascending
stairs. Given this acute worsening, she was admitted to
the hospital. On admission her strength was abnormal;
she would brace herself against furniture to stand and
had a positive Gowers’ sign. Direct strength testing
against resistance was difficult to obtain, but knee extension, plantar flexion, dorsiflexion and toe flexion were 4/
5 bilaterally. She had a wide-based gait and had difficulty
fully lifting her feet off the ground while ambulating.
Otherwise, her neurological exam was normal regarding
her mental status, cranial nerves, deep tendon reflexes,
sensation, coordination, and upper extremity strength.
Complete metabolic panel, creatine kinase, aldolase,
lactate dehydrogenase, uric acid, thyroid stimulating
hormone, vitamin D level, and acetylcholine receptor
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Table 1 Select laboratory results
Laboratory test

Value

White blood cell count

5.46 × 103/μL

Hemoglobin

10.2 g/dL

Platelet count

253 × 103/μL

Creatinine

0.36 mg/dL

Aspartate aminotransferase

42 u/L

Alanine aminotransferase

31 u/L

Lactate dehydrogenase

746 u/L

Creatine kinase

230 u/L

Aldolase

4.5 u/L

Erythrocyte sedimentation rate

11 mm/hr

C reactive protein

0.6 mg/dL

Thyroid stimulating hormone

4.1 mIU/L

Vitamin D 25-OH

32 ng/mL

Iron

22 μg/dL

Total iron-binding capacity

481 μg/dL

Transferrin saturation

5%

Ferritin

5 ng/mL

Vitamin C

< 0.1 mg/dL

binding antibody were all within normal limits (Table 1).
A brain magnetic resonance imaging (MRI) was normal,
and a spine MRI was remarkable for a small amount of
fat within the filum terminale. Lumbar puncture showed
normal cerebrospinal fluid protein, mildly low glucose
(48 mg/dL), 1 white blood cell, no red blood cells, and
negative enterovirus. MRI of the lower extremities demonstrated increased signal and enhancement of the right
paraspinal musculature and bone marrow edema within
the right sacral ala, posterior acetabulae, and distal femoral metaphyses. Electromyogram and nerve conduction
studies were normal. Plasma amino acids, urine organic
acids, acylcarnitine profile, ammonia, and homocysteine
were normal. Iron studies demonstrated low iron (22 μg/
dL), elevated total iron-binding capacity (481 μg/dL),
and low transferrin saturation (5%) (Table 1).
On hospital day 6, her vitamin C level, which had been
obtained upon admission in light of her having a restricted diet, returned as undetectable at < 0.1 mg/dL.
Upon further questioning, the patient refused to eat
fruits or vegetables; her diet at home consisted of dairy
products, bread, and crackers. She was started on ascorbic acid 100 mg 3 times daily and had improved strength
within 24 h of her first dose. She was discharged shortly
thereafter with a diagnosis of scurvy. She returned to
her baseline within 2 to 3 weeks. At her follow-up neurology and rheumatology visits, she had a normal neurologic exam including strength and gait. Laboratory
results 11 weeks post-discharge demonstrated improving
hemoglobin level (11.3 g/dL; MCV 73.7 fL, RDW 13.8%)
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and normal vitamin C level (1.1 mg/dL). She saw a dietician, who recommended dietary and behavioral modifications and continuation of ascorbic acid supplementation.

Discussion
Scurvy is a preventable disease caused by poor intake
and/or absorption of vitamin C. Fruits and vegetables
are the primary dietary source of this essential vitamin.
Typically, the first symptoms of scurvy are nonspecific,
including fatigue, anorexia and weight loss; these appear after 60 to 90 days of a diet lacking ascorbic acid
[4, 9, 10]. Cutaneous findings, including petechiae, ecchymoses, hyperkeratosis, corkscrew hairs, and perifollicular hemorrhage, can develop after about 5 months of a
diet deficient in vitamin C and are frequently found in the
lower extremities because the capillaries also face hydrostatic pressure [4, 9, 10]. Many cutaneous manifestations
are secondary to blood vessel fragility as ascorbic acid is
paramount in collagen synthesis [4]. In the gingiva, this is
seen as erythema, swelling, and teeth loss [4]. Anemia is
common and partially due to iron deficiency, because vitamin C aids in iron absorption. Additional manifestations
can include lower extremity edema, splinter hemorrhages,
alopecia, poor wound healing, cardiac hypertrophy,
psychological changes, and conjunctival hemorrhages,
among many others [4].
Pediatric patients commonly present with musculoskeletal manifestations. With damage to synovial blood
vessels and microfractures, there is pain and swelling
secondary to subperiosteal hemorrhages and hemarthroses [9]. Osteoporosis may develop within the
trabeculae and cortical bone, sites of endochondral
ossification, which require collagen to develop a strong
osteoid matrix [11]. Additionally, vitamin C deficiency
increases bone resorption [9].
Case reports of musculoskeletal manifestations with
scurvy are often accompanied by classic skin or mucosal
changes. A case series from Thailand reported that 96%
of children diagnosed with scurvy presented with inability to walk [12]. In this cohort, 96% also had limb pain,
43% had gingival bleeding, 46% had lower extremity
joint swelling, 36% had gum hypertrophy, and 3.6% had
petechial hemorrhage. Another report highlights a 12year-old boy with scurvy who presented with leg pain
and refusal to bear weight [2]. However, in contrast to
our child, he had global developmental delay, skin findings, and mucosal changes. Similarly, another case report highlights a 9-year-old patient with progressive leg
weakness and musculoskeletal pain, but examination
was also pertinent for gum hypertrophy, mucosal bleeding, ecchymosis, and hyperkeratosis [13]. There are additional reports of infants presenting with pseudoparalysis
due to presumed leg pain [11, 12] and patients presenting with joint swelling [14, 15]. The lack of other
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symptoms in our patient may be due to her disease
being in an early stage or due to a mild form of the
disease.
Pediatric scurvy frequently has classic radiographic
findings, which were not seen in our patient. These findings include cortical thinning, zone of provisional calcification at the metaphysis (lines of Fränkel), lucent
metaphyseal band (Trümmerfeld zone), metaphyseal
spurs (Pelkan spurs), or calcification around the epiphysis (Wimberger ring sign) [1, 5, 11, 14]. In a case series
of 3 children diagnosed with scurvy who presented with
difficulty walking, all patients had radiographs containing lines of Fränkel [1]. In another case report involving
a child who had difficulty walking, radiographs demonstrated lines of Fränkel and metaphyseal spurs [14]. Our
patient’s radiographs showed only osteopenia, the most
common yet nonspecific finding in scurvy [5, 11]. Our
patient also had an abnormal MRI demonstrating areas
of increased bone marrow signal, which is nonspecific
but was reported in all four cases in the largest case
series of MRI findings in pediatric scurvy [6]. Furthermore, this case series noted signal abnormalities centered in the metaphyses, and the distal femoral
metaphyses were involved in our patient.
Given the dietary deficiency needed to cause scurvy,
this disease is mainly seen in elderly people, alcoholics,
and food faddists [4, 9]. Scurvy is less common in the
pediatric population, with most reports in patients with
severe dietary restrictions secondary to developmental
delay, autism, or psychiatric disorders [2, 5–8]. Other
pediatric risk factors include ketogenic diet, chronic
total parenteral nutrition usage, malignancy, poor
intestinal absorption, food allergies, or infants fed
boiled milk [9–11, 16].

Conclusions
Our case is notable given our patient was developmentally normal without autistic characteristics. In addition,
she presented solely with an abnormal gait and weakness
without other characteristic findings of scurvy, resulting
in an extensive neurologic work-up. Our case highlights
the importance of obtaining a dietary history in patients
with unknown diagnoses. We recommend administration
of empiric ascorbic acid while awaiting lab verification if
the history is concerning for poor vitamin C intake. In
addition, our case emphasizes the need to consider scurvy
as a possible, albeit rare, diagnosis for a child with unexplained limp or lower extremity weakness.
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